Securities code: 301080 securities abbreviation: Acrobiosystems Co.Ltd(301080) Announcement No.: 2022-002 Acrobiosystems Co.Ltd(301080)
Announcement of resolutions of the 13th meeting of the first board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of directors
The 13th meeting of the first board of directors of Acrobiosystems Co.Ltd(301080) (hereinafter referred to as “the company”) was held by means of communication voting at 11:30 a.m. on January 24, 2022 in the conference room of the company, No. 8 Hongda North Road, Beijing Economic and Technological Development Zone, Beijing. The notice and meeting materials of this meeting were sent by hand, fax and e-mail on January 23, 2022. This meeting is an emergency meeting. According to the relevant provisions of the articles of association, all directors of the company agreed to waive the notice time limit of this meeting of the board of directors. There are 7 directors who should attend the meeting and 7 directors who actually participate in the communication meeting. The meeting was presided over by Mr. Chen Yiding, chairman of the board of directors, and the supervisors and senior managers of the company attended the meeting as nonvoting delegates. The convening and convening of the meeting shall comply with laws, regulations, rules and the provisions of the articles of association.
2、 Deliberations of the board meeting
The directors attending the meeting unanimously passed the following resolutions:
The proposal on participating in investment in Tianjin Kangcheng Bain equity investment fund partnership (limited partnership) was deliberated and adopted
It is agreed that the company will participate in the investment of Tianjin Kangcheng Bain equity investment fund partnership (limited partnership) (tentative name, subject to the subsequent industrial and commercial registration). The total amount of capital contribution to be subscribed by the fund is 150 million yuan, and the company plans to subscribe 50 million yuan. The capital source of this investment is its own capital.
For details, please refer to the company’s disclosure on cninfo.com on the same day（ http://www.cn.info.com.cn. ）Announcement on participating in investment in Tianjin Kangcheng Baien equity investment fund partnership (limited partnership). Voting results: 7 in favor, 0 against and 0 abstention.
3、 Documents for future reference
Resolution of the 13th meeting of the first board of directors. It is hereby announced.
Acrobiosystems Co.Ltd(301080) board of directors January 25, 2022
